Boston Partners’s Ortho Clinical Diagnostics Holdings OCDX Stock Holding History
Bought
Maintained
Sold
Other funds holding OCDX
Boston Partners's OCDX Position: Q2 2022 in Review
Boston Partners sold out of Ortho Clinical Diagnostics Holdings (OCDX) in Q2 2022, closing a stake of 2,792,201 shares — an estimated $52.3M sold.
Boston Partners first reported a position in OCDX in Q1 2021 and held it in 5 quarters. The position peaked at $61.3M in Q2 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.
- Boston Partners reported no remaining Ortho Clinical Diagnostics Holdings position as of Q2 2022 after selling out during the quarter.
- Boston Partners sold 2,792,201 Ortho Clinical Diagnostics Holdings shares in Q2 2022, an estimated $52.3M.
- Boston Partners first reported a position in Ortho Clinical Diagnostics Holdings in Q1 2021 and held it in 5 quarters.
- Boston Partners's Ortho Clinical Diagnostics Holdings position peaked at $61.3M in Q2 2021.
- 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings as of Q2 2022.
Based on Boston Partners's 13F filing for Q2 2022, filed 10 Aug 2022.